TWI349549B - Medicament for treatment of intraocular angiopoietic disease - Google Patents
Medicament for treatment of intraocular angiopoietic diseaseInfo
- Publication number
- TWI349549B TWI349549B TW093103856A TW93103856A TWI349549B TW I349549 B TWI349549 B TW I349549B TW 093103856 A TW093103856 A TW 093103856A TW 93103856 A TW93103856 A TW 93103856A TW I349549 B TWI349549 B TW I349549B
- Authority
- TW
- Taiwan
- Prior art keywords
- intraocular
- medicament
- treatment
- angiopoietic
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003109918 | 2003-04-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200503684A TW200503684A (en) | 2005-02-01 |
TWI349549B true TWI349549B (en) | 2011-10-01 |
Family
ID=33295936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093103856A TWI349549B (en) | 2003-04-15 | 2004-02-18 | Medicament for treatment of intraocular angiopoietic disease |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070203211A1 (zh) |
EP (2) | EP2517728B1 (zh) |
JP (2) | JP4489020B2 (zh) |
KR (1) | KR101087519B1 (zh) |
CN (1) | CN1798576B (zh) |
BR (1) | BRPI0409293A (zh) |
CA (1) | CA2522318C (zh) |
ES (1) | ES2535291T3 (zh) |
TW (1) | TWI349549B (zh) |
WO (1) | WO2004091659A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009087900A1 (ja) * | 2008-01-11 | 2009-07-16 | Daiichi Sankyo Company, Limited | 眼内血管透過性亢進を伴う疾患の予防または治療のための医薬 |
KR100893652B1 (ko) * | 2008-11-10 | 2009-04-17 | 주식회사종근당 | 신규한 텔미사르탄 아연염 및 그의 제조방법 |
JP5860210B2 (ja) * | 2010-12-07 | 2016-02-16 | 株式会社オフテクス | アンジオテンシンii受容体拮抗薬であるテルミサルタン及びロサルタンの少なくとも1種を有効成分とする涙液分泌促進用組成物、及びそれを含有する涙液分泌促進用経口投与用製剤 |
JP6010441B2 (ja) * | 2011-12-06 | 2016-10-19 | 株式会社ハイマート | ノコギリヤシ果実のエタノール抽出物または赤色素を含有する血管新生抑制剤および赤色素の製造方法 |
ES2954171T3 (es) * | 2016-07-20 | 2023-11-20 | P&X Medical Nv | Compuestos para su uso en métodos para tratar glaucoma y enfermedades de la retina |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2229000C (en) | 1991-02-21 | 2002-04-09 | Sankyo Company, Limited | 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
ATE199548T1 (de) * | 1992-06-02 | 2001-03-15 | Sankyo Co | 4-carboxyimidazolderivate als angiotensin-ii- antagonisten und ihre therapeutische verwendung |
DE69534339T2 (de) * | 1994-02-08 | 2006-05-24 | Novartis Ag | Behandlung von normaldruckglaukom mit valsartan |
WO1995024902A1 (fr) * | 1994-03-16 | 1995-09-21 | Sankyo Company, Limited | Reducteur de tension oculaire |
EP1197223B1 (en) * | 1999-04-28 | 2005-02-16 | Takeda Pharmaceutical Company Limited | Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy |
JP4276768B2 (ja) | 1999-04-28 | 2009-06-10 | 武田薬品工業株式会社 | 単純網膜症・前増殖網膜症の予防・治療・進展抑制剤 |
AR033390A1 (es) * | 2000-08-22 | 2003-12-17 | Novartis Ag | Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes |
JP4132798B2 (ja) * | 2000-12-05 | 2008-08-13 | 第一三共株式会社 | 局所投与のための眼圧低下組成物 |
AU2002218527A1 (en) * | 2000-12-05 | 2002-06-18 | Sankyo Company Limited | Ocular tension-lowering compositions for topical administration |
EP1369130A1 (en) * | 2001-03-16 | 2003-12-10 | Takeda Chemical Industries, Ltd. | Process for producing sustained release preparation |
US20040132731A1 (en) * | 2002-06-26 | 2004-07-08 | Fox David Nathan Abraham | Novel combination |
US20050038093A1 (en) * | 2003-05-02 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Treating diabetic retinopathy with angiotensin II receptor blockers |
-
2004
- 2004-02-18 ES ES12175765.2T patent/ES2535291T3/es not_active Expired - Lifetime
- 2004-02-18 CA CA2522318A patent/CA2522318C/en not_active Expired - Fee Related
- 2004-02-18 TW TW093103856A patent/TWI349549B/zh not_active IP Right Cessation
- 2004-02-18 BR BRPI0409293-7A patent/BRPI0409293A/pt not_active Application Discontinuation
- 2004-02-18 EP EP12175765.2A patent/EP2517728B1/en not_active Expired - Lifetime
- 2004-02-18 WO PCT/JP2004/001818 patent/WO2004091659A1/ja active Application Filing
- 2004-02-18 KR KR1020057019316A patent/KR101087519B1/ko not_active IP Right Cessation
- 2004-02-18 EP EP04712221A patent/EP1614428A4/en not_active Withdrawn
- 2004-02-18 JP JP2005505338A patent/JP4489020B2/ja not_active Expired - Fee Related
- 2004-02-18 CN CN2004800150179A patent/CN1798576B/zh not_active Expired - Fee Related
-
2005
- 2005-10-04 US US11/243,656 patent/US20070203211A1/en not_active Abandoned
-
2010
- 2010-01-08 JP JP2010003247A patent/JP2010143933A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2535291T3 (es) | 2015-05-08 |
CA2522318C (en) | 2011-09-13 |
JP4489020B2 (ja) | 2010-06-23 |
KR20050120714A (ko) | 2005-12-22 |
CN1798576A (zh) | 2006-07-05 |
EP1614428A1 (en) | 2006-01-11 |
BRPI0409293A (pt) | 2006-04-11 |
WO2004091659A1 (ja) | 2004-10-28 |
EP2517728A1 (en) | 2012-10-31 |
JPWO2004091659A1 (ja) | 2006-07-06 |
EP2517728B1 (en) | 2015-01-28 |
CA2522318A1 (en) | 2004-10-28 |
EP1614428A4 (en) | 2010-01-06 |
KR101087519B1 (ko) | 2011-11-28 |
JP2010143933A (ja) | 2010-07-01 |
US20070203211A1 (en) | 2007-08-30 |
TW200503684A (en) | 2005-02-01 |
CN1798576B (zh) | 2012-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1500043I1 (hu) | Eljárások Parkinson-kór kezelésére | |
EG24420A (en) | Treatment of ophthalmic conditions | |
IL176629A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
TWI372056B (en) | Novel medicament combinations for the treatment of respiratory diseases | |
AP2006003669A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
HK1079993A1 (en) | Drugs for treating vascular diseases | |
GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
EP1680145A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES | |
GB0320238D0 (en) | Treatment of disease | |
EP1542664A4 (en) | METHODS AND COMPOSITIONS FOR TREATING MACULAR AND RETINAL DISORDERS | |
EP1675547A4 (en) | GLUCOCEREBROSIDE TREATMENT OF ILLNESSES | |
EP1768656A4 (en) | TREATMENT OF OCULAR DISEASES | |
IL174595A0 (en) | Glucocerebroside treatment of disease | |
TWI349549B (en) | Medicament for treatment of intraocular angiopoietic disease | |
IL178120A0 (en) | Therapeutic combination for treatment of alzheimers disease | |
TWI315984B (en) | Agent for treatment of anal disease | |
GB0428218D0 (en) | Medicament for Treatment of Inflammatory Diseases | |
GB0327493D0 (en) | Treatment medicament | |
TWI350752B (en) | Pharmaceutical composition for the treatment of connective tissue disease | |
HU0302933D0 (en) | Treatment of diseases | |
GB0208194D0 (en) | Treatment of disease | |
AU2003300471A8 (en) | Methods for treating ocular diseases | |
GB0319715D0 (en) | Treatment of auto-inflammatory disease | |
GB0702858D0 (en) | Dressinf for tissue treatment | |
GB0315877D0 (en) | Compounds for the treatment of disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |